Mr Peter Larsen, who was instrumental in bringing Specsavers to Australia 13 years ago, has returned to Melbourne after moving to the company’s UK headquarters to serve as its first-ever group eye health strategy director. Read more

Mr Peter Larsen, who was instrumental in bringing Specsavers to Australia 13 years ago, has returned to Melbourne after moving to the company’s UK headquarters to serve as its first-ever group eye health strategy director. Read more
ASX-listed AFT Pharmaceuticals has expanded its therapeutics range with a new dry eye therapy containing Omega-3. Read more
A proposed merger between two pharmaceutical companies that compete in the glaucoma treatment markets has been given the green light – with one major stipulation. Read more
Australian eyewear retailer Oscar Wylee has been ordered to pay $3.5 million in penalties for misleading or deceptive conduct and making false or misleading representations about its charitable donations and affiliations. Read more
Safilo has unveiled the latest female collection from Italian luxury fashion brand Missoni to the Australian optical market Read more
Multinational ophthalmic device company Topcon has expanded its footprint in Australia with the introduction of a business segment overseeing the roll out of a new software platform that connects all ophthalmic imaging devices regardless of the manufacturer.
Patients of Australian optometry practices that are linked with the MyHealth1st appointment booking platform now have access to a buy now, pay later (BNPL) payment option. Read more
Specsavers co-founder Mr Doug Perkins has made a special appearance to announce Australia and New Zealand’s top-performing practices, which received a medal named in his honour. Read more
A US company that has incorporated dark adaptometry into a new wearable headset for age-related macular degeneration (AMD) is on the cusp of introducing the AI-guided technology to the Australian ophthalmic market. Read more
Adelaide ophthalmic device manufacturer Nova Eye Medical is developing a next generation iTrack glaucoma surgical system to reduce operating times. It is also progressing towards a pivotal US study for its 2RT laser therapy for intermediate AMD that could fulfil a distinct gap in a multi-billion-dollar market. Read more